A number of medications have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of attention-deficit/hyperactivity disorder (ADHD), and the evidence for the effectiveness of pharmacotherapy in ADHD is strong.
European guidelines on managing adverse effects of medication for ADHD. European Child Adolescent Psychiatry 20:17-37, 2011.Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., & Taylor, E. (2011). European guidelines on managing adverse ...
MedicationAdverseGuidelinesEuropeanChildrenThe safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These ...
Side effects were common and contributed to negative feelings toward medication. Some adolescents had begun to use medication selectively. Many expressed uncertainty about future use of medication. Conclusions Adolescents assume an increasing role in managing medication for ADHD. Well-structured and ...